[Treatment of the leprous reaction of erythema nodosum type with 1-(2-hydroxyethyl)-2-methyl-5-nitromidazole (metronidazole-Flagyl)].
D002097:C-Reactive Protein; D002986:Clinical Trials as Topic; D004893:Erythema Nodosum / Q000188:drug therapy*; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D008795:Metronidazole / Q000627:therapeutic use*
D008795:Metronidazole; D002097:C-Reactive Protein
Traitement de la réaction lépreuse à type d'érythème noueux par l'(hydroxy-2' éthyl)-1 méthyl-2 nitro-5 imidazole (métronidazole-Flagyl)